Unlock instant, AI-driven research and patent intelligence for your innovation.
A kind of medicine for treating thromboangiitis obliterans
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for thrombosis and vasculitis, which is applied in the field of drugs for the treatment of thromboangiitis obliterans, can solve the problems of high treatment cost, great pain, damage to other organs, etc., and achieve the effect of simple usage, fast curative effect, and less recurrence
Active Publication Date: 2014-10-22
王向飞
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although the above-mentioned treatment methods can play a certain therapeutic effect, they are at the cost of damaging other organs, and cannot be cured fundamentally. Moreover, the treatment costs are high and the pain is great. In the later stage, amputation must be performed to save life.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0023] A medicine for treating thromboangiitis obliterans, which is made from the following components, and the dosage is in parts by weight: 10-90 grams of honeysuckle, 10-20 grams of polygala, 3-10 grams of Chuanxiong, and 3-12 grams of Bupleuri , Scutellaria 3-12 grams, Radix Astragali 3-18 grams, Safflower 3-13 grams, Angelica 3-13 grams, Forsythia 3-13 grams, Poria cocos 3-12 grams, Nepeta 3-15 grams, Licorice 3-9 grams gram.
Embodiment 2
[0025] A medicine for treating thromboangiitis obliterans, which is made from the following components, and the dosage is in parts by weight: 10-90 grams of honeysuckle, 10-20 grams of polygala, 3-10 grams of Chuanxiong, and 3-12 grams of Bupleuri , Scutellaria 3-12 grams, Radix Astragali 3-18 grams, Safflower 3-13 grams, Angelica 3-13 grams, Forsythia 3-13 grams, Poria cocos 3-12 grams, Nepeta 3-15 grams, Licorice 3-9 grams gram, Notopterygium 3-12 grams, Campanula 3-20 grams, Akebia 3-13 grams.
Embodiment 3
[0027] A medicine for treating thromboangiitis obliterans, which is made from the following components, and the dosage is in parts by weight: 10-90 grams of honeysuckle, 10-20 grams of polygala, 3-10 grams of Chuanxiong, and 3-12 grams of Bupleuri , Scutellaria 3-12 grams, Radix Astragali 3-18 grams, Safflower 3-13 grams, Angelica 3-13 grams, Forsythia 3-13 grams, Poria cocos 3-12 grams, Nepeta 3-15 grams, Licorice 3-9 grams gram, Notopterygium 3-12 grams, Campanula 3-20 grams, Akebia 3-13 grams, Achyranthes bidentata 3-12 grams.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a medicine for treating thromboangitis obliterans. The medicine is prepared from the following ingredients by weight: 10-90 grams of honeysuckle, 10-20 grams of polygala tenuifolia, 3-10 grams of ligusticum chuanxiong, 3-12 grams of radix bupleuri, 3-12 grams of radix scutellariae, 3-18 grams of astragalus, 3-13 grams of safflower, 3-13 grams of angelica sinensis, 3-13 grams of forsythia, 3-13 grams of poria cocos, 3-15 grams of schizonepeta and 3-9 grams of liquorice. The medicine has the functions of warming channel to remove coldness, promoting circulation and removing stasis, regulating vital energy and stopping pain, so that the purposes of controlling the disease development, avoiding amputation, relieving pain of patients and lowering the treatment cost are achieved. The medicine further has the characteristics that taking is convenient, carrying is easy and side effects are small.
Description
technical field [0001] The invention belongs to the technical field of traditional Chinese medicine products, and mainly relates to a medicine for treating thromboangiitis obliterans. Background technique [0002] Thromboangiitis obliterans is called "thromboangiitis" in traditional Chinese medicine. Such diseases include acute, subacute and chronic and systemic vascular diseases. It is a chronic, occlusive, inflammatory disease that occurs in peripheral blood vessels, often accompanied by secondary neuropathy, mainly in the middle and small arteries and veins of the extremities, especially in the lower extremities. The clinical symptoms can be divided into three stages according to the degree of limb ischemia: 1. Ischemic stage: symptoms of vasculitis include numbness, coolness, mild intermittent claudication, and recurring superficial migratory phlebitis. Examination revealed that the skin temperature of the affected limb was slightly lower, the color was paler, and ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
